Plain-English translation of NCT05305482 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a heart attack, doctors place a stent (a small metal tube) in your blocked artery to restore blood flow. This trial is testing whether a newer type of stent called a drug-coated stent works as well as the standard drug-eluting stent when patients take blood-thinning medication for only one month instead of longer. Both stents release medication to prevent the artery from closing again.
Current treatment requires taking blood-thinning medications for extended periods after a heart attack stent, which can increase bleeding risk and cost. Researchers want to know if a shorter treatment period — just one month — is safe and effective with the newer stent type.
You likely qualify if…
You likely don't qualify if…
You will receive one of the two stent types during your heart attack treatment (decided randomly). For the first month, you'll take aspirin and ticagrelor (two blood-thinning medications) together. After one month, you'll continue taking ticagrelor alone for 11 more months. During the year-long study, your doctor will track your health for any heart-related events and complications, through follow-up visits and check-ins.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
South Korea